Evidence map›Paper›PMID 23681158›Full record

ReviewPsychopharmacology2013

Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Tamar L Gur, Deborah R Kim, C Neill Epperson

Open access · greenAbstract readReview
In one paragraph

Review in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Novel aspects of enteric serotonergic signaling in health and brain-gut disease.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Review
  3. Article
  4. Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2017
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tamar L GurPenn Center for Women's Behavioral Wellness, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania Philadelphia, 3535 Market St, 3rd Floor, Philadelphia, PA 19104, USA.
Deborah R Kim
C Neill Epperson
University of Pennsylvania · USPenn Center for AIDS Research · US

Funding

Prepubertal Stress, Windows of Risk & Sex Bias for Affective DisturbanceP50MH099910 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KIM, DEBORAH · 2012 to 2017
$6.5M
Clinical research scholars programs in psychiatryR25MH060490 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI EVANS, DWIGHT L. · 1999 to 2013
$3.5M
Neuroendocrine Contribution to Behavior & Cognition in the Female LifespanK24DA030301 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI EPPERSON, C. NEILL · 2010 to 2014
$954k
Transcranial Magnetic Stimulation in Pregnant Women with Depressive DisorderK23MH092399 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KIM, DEBORAH · 2011 to 2015
$886k
NIDA NIH HHS K24 DA030301NIDA NIH HHS K24DA030301NIMH NIH HHS K23 MH092399NIMH NIH HHS P50 MH099910NIMH NIH HHS P50MH099910NIMH NIH HHS R25 MH060490
6 · The paper itself

Abstract

rationaleWomen are increasingly prescribed selective serotonin reuptake inhibitors (SSRIs) during pregnancy, with potential implications for neurodevelopment. Whether prenatal SSRI exposure has an effect on neurodevelopment and behavior in the offspring is an important area of investigation.

objectivesThe aim of this paper was to review the existing preclinical and clinical literature of prenatal SSRI exposure on serotonin-related behaviors and markers in the offspring. The goal is to determine if there is a signal in the literature that could guide clinical care and/or inform research.

resultsPreclinical studies (n = 4) showed SSRI exposure during development enhanced depression-like behavior. Half of rodent studies examining anxiety-like behavior (n = 13) noted adverse effects with SSRI exposure. A majority of studies of social behavior (n = 4) noted a decrease in sociability in SSRI exposed offspring. Human studies (n = 4) examining anxiety in the offspring showed no adverse effects of prenatal SSRI exposure. The outcome of one study suggested that children with autism were more likely to have a mother who was prescribed an SSRI during pregnancy.

conclusionsPreclinical findings in rodents exposed to SSRIs during development point to an increase in depression- and anxiety-like behavior and alteration in social behaviors in the offspring, though both the methods used and the findings were not uniform. These data are not robust enough to discourage use of SSRIs during human pregnancy, particularly given the known adverse effects of maternal mental illness on pregnancy outcomes and infant neurodevelopment. Future research should focus on consistent animal models and prospective human studies with larger samples.

Indexed as

AnimalsFemaleFetal DevelopmentHumansMajor Depressive DisorderMental DisordersPregnancyPregnancy ComplicationsPrenatal Exposure Delayed EffectsRodentiaSelective Serotonin Reuptake InhibitorsSerotoninSelective Serotonin Reuptake InhibitorsSerotonin

Identifiers

PMID23681158
PMCPMC3838633
OpenAlexW2059929133

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.